Based on the application of 74 MMR gene variations and clinical data, the three-step assessment model seems to be a valuable tool for correctly identifying pathogenic MMR gene mutations, which in turn, permits predictive gene testing in the family and enables targeted cancer surveillance. This evidence concerns the gene MRC1 and cancer.